Syphilis Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Syphilis Testing Market Forecast 2024-2028

The global syphilis testing market size is estimated to grow by USD 2.22 billion at a CAGR (Compound Annual Growth Rate) of 6.7% between 2023 and 2028. 

The rising focus on vertical transmission prevention is a major driver in the market. The market is experiencing a growing emphasis on preventing vertical transmission. Vertical transmission refers to the transmission of syphilis from an infected mother to her fetus or newborn. This form of transmission can result in various severe health complications for the child, including stillbirth, neonatal death, and long-term disabilities. Additionally, public health campaigns play a crucial role in preventing vertical transmission of syphilis. These campaigns actively aim to raise awareness about syphilis, its modes of transmission, and the significance of testing and treatment. They also provide education and resources to healthcare providers, assisting them in recognizing and managing syphilis in pregnant women. Hence, such factors are expected to increase the demand for tests.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by End-user, Technology, and Geography Analysis

This report provides a detailed analysis of the market by technology (conventional testing and POC testing),  end-user (water and waste treatment, food and beverage, pharmaceutical, and others), and geographic landscape (APAC, Europe, MEA, North America, and South America).

End-user Analysis 

The market share growth by the primary and secondary syphilis segments will be significant during the forecast period. Primary and secondary syphilis are the early stages of infection and require prompt diagnosis and treatment to prevent the progression of the disease and mitigate potential complications.

Get a glance at the market contribution of various segments View a PDF Sample

The primary and secondary syphilis segment were the largest and was valued at USD 3.56 billion in 2018. Effective testing and diagnosis of primary and secondary syphilis are crucial to guide appropriate treatment and prevent further transmission of the infection. Timely identification of these early stages of syphilis allows for early intervention and reduces the risk of complications, such as neurosyphilis or cardiovascular involvement. Thus, the above-mentioned advantages are expected to increase the demand for primary and secondary syphilis, which will propel the growth of the primary and secondary segment in the market during the forecast period.

Technology  Analysis 

The laboratory testing or conventional testing segment of the market includes serology tests and direct detection tests. Serology tests detect antibodies from the blood and the cerebrospinal fluid (CSF).  Furthermore, many POC devices are yet to be approved by the regulatory health authorities, thus leading to increased demand for conventional tests, especially in developing regions, because of the lack of availability, affordability, and awareness about the approved POC testing devices. Also, it will be in demand in the future because it is a primary and confirmative test performed by all laboratories and hospitals. Thus, the abovementioned advantages are expected to increase the demand for conventional testing, which will propel the growth of the laboratory testing or conventional testing segment in the market in focus during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The market in North America is led by the US and is driven by the growing prevalence of STDs, a strong presence of vendors such as Johnson and Johnson Pvt. Ltd. (J and J), Pfizer Inc (Pfizer), AbbVie Inc (AbbVie), and Abbott Laboratories (Abbott), and the availability of prevalence of syphilis testing to prevent syphilis. The region witnessed regular health check-ups as part of the wellness programs initiated by the government and non-government organizations, thereby increasing the demand for syphilis testing. 

In addition, the Public Health Agency of Canada has set up the Pan-Canadian Sexually Transmitted and Blood-Borne Infections (STBBI) framework. This framework provides a roadmap for collaborative action to reduce the impact of STBBI across Canada and, thus, contributes to the global effort to end HIV and other STDs, which are major health concerns across the world. Such factors are expected to drive the market growth during the forecast period. 

Market Dynamics and Customer Landscape

The market is witnessing significant growth driven by increasing awareness and the prevalence of sexually transmitted infections like syphilis. Blood tests play a crucial role in diagnosing this condition, with the market size expanding due to factors like favorable reimbursement policies and technological advancements in testing kits.

Tertiary syphilis and its complications, including multi-organ infections, neurological damage, and stillbirth, highlight the urgency of early detection. Tests targeting specific antibodies are vital, especially among high-risk groups such as injecting drug users and sex workers. The market dynamics include evolving consumer behavior, challenges in reaching the geriatric population, and advancements in laboratory testing methods. As the market landscape evolves, maintaining convenient and confidential testing procedures will be pivotal during the forecast period.

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

The market growth is significantly fueled by the increasing adoption of Point-of-Care (POC) testing devices, which are revolutionizing the diagnostics sector. Notable trends include the downsizing of devices, the decentralization of testing centers closer to patient locales, and the emergence of multi-parameter checking devices. A significant shift in the diagnostics sector is towards Point-of-Care (POC) diagnostics or testing, which miniaturizes laboratory functions onto portable systems, enabling the quantification of individual living cells and small volumes of reagents. Technologies such as sensors, microsystems, and low-cost imaging facilitate self-contained and portable devices for disease detection and diagnosis. For instance, Alere's Determine Syphilis TP is a rapid POC test for detecting antibodies for Treponema pallidum, providing results within 15 minutes. This trend is expected to drive the demand for syphilis tests and propel market growth during the forecast period, addressing concerns regarding sexually transmitted infections and related complications like tertiary syphilis, multi-organ infections, neurological damage, and stillbirths.

Significant Market Trends

Expansion of the diagnostic laboratory industry is an emerging trend shaping the market growth. Diagnostic laboratories play a crucial role in the identification and diagnosis of infections, contributing to the overall management and control of the disease. Various factors, including advancements in technology, increasing demand for accurate and timely testing, and the growing burden of syphilis globally, drive this expansion. The growing burden of syphilis globally also contributes to the expansion of the diagnostic laboratory industry. Syphilis remains a significant public health concern, with increasing incidence rates reported in many countries. As the prevalence of rises, the demand for testing services also increases. Diagnostic laboratories are critical in providing accurate and timely diagnosis of infections, allowing for appropriate treatment and prevention of further transmission.

Moreover, some laboratories focus specifically on testing, dedicating their resources and expertise to provide comprehensive and targeted testing services. These specialized facilities often have state-of-the-art equipment and highly trained staff, offering high-quality testing with quick turnaround times. The establishment of such facilities enhances the capacity to meet the increasing demand for testing and supports the overall management and control of the disease. Hence, such factors are expected to drive the growth of the market during the forecast period.

Major Market Challenges

The high cost of syphilis diagnostic tests is a significant challenge hindering market growth. Cost-effectiveness is an important factor for diagnostic tests. Newer syphilis diagnostic test instruments such as molecular tests and immunoassays, increase the budget of laboratories. The high cost of upgrading to new technologies is a major factor contributing to the high cost of syphilis diagnostics tests. Frequent advances in technology and the development of new diagnostic tests are required for different diagnostic tests. Also, recurring changes in regulations to ensure compatibility between devices have resulted in the expensive upgrading of diagnostic equipment. This upgrade process is an additional financial burden for low- and average-income laboratories in the market.

Consequently, users are reluctant to upgrade existing devices or buy advanced and expensive infectious disease diagnostic devices. Also, home test kits range from USD 20 to USD 50, which is expensive, especially for users in developing countries where the price is a major purchasing criterion. This reluctance from end-users limits the adoption of tests, which will restrict the growth of the global market during the forecast period.

Buy Now Full Report and Discover More

Customer Landscape

The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Buy Now Full Report and Discover More

Key Syphilis Testing Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market growth and forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Abbott Laboratories - The company offers syphilis testing kits such as Bioline Syphilis 3.0 test which is a solid phase immunochromatographic assay for the qualitative detection of antibodies of all isotypes IgG, IgM, IgA against Treponema pallidum TP.

Other companies include:

• AdvaCare Pharma, Beckman Coulter Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• bioLytical Laboratories Inc.
• Bloodworks Northwest
• Calibre Scientific Inc.
• Danaher Corp.
• DiaSorin SpA
• Everlywell Inc.,
• F. Hoffmann La Roche Ltd.
• Hologic Inc.,
• LetsGetChecked
• Meril Life Sciences Pvt. Ltd.,
• OK Biotech Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The Syphilis Testing Market is integral to detecting and combating the sexually transmitted infection caused by the bacterium Treponema pallidum. With its various stages - primary, secondary, latent, and tertiary - syphilis poses severe health risks, including multi-organ infections and neurological damage. The market offers diagnostic tests such as VDRL and RPR blood tests, crucial for early detection and treatment. Factors such as rising incidence rates, particularly among populations like men who have sex with men (MSM), injecting drug users, and sex workers, underscore the importance of prevention and control measures. Technological advancements have led to the development of convenient, cost-efficient point-of-care testing, catering to the geriatric population. With favorable reimbursement policies, the market is witnessing a surge in demand, driven by consumer behavior and a focus on confidentiality in testing procedures. This dynamic landscape fosters competition among leading companies, driving innovation and ensuring the market's continued growth.

The syphilis testing market is a critical aspect of STD prevention and control, particularly amidst the rise in incidence and prevalence rates, notably among the MSM (Men who have sex with men) population. Syphilis, caused by the bacterium Treponema pallidum, progresses through distinct stages, from the primary stage with open sores to the tertiary stage with severe complications like vascular damage and lesions. Early detection through tests like Rapid Plasma Reagin (RPR) and Venereal Disease Research Laboratory (VDRL) tests is crucial, especially considering congenital syphilis risks. Point-of-care testing has emerged as a cost-efficient solution, driving economic shifts in the industry. With a competitive landscape and concentration ratio, ongoing industry research focuses on enhancing diagnostic accuracy and efficiency to address asymptomatic syphilis cases and control transmission effectively.

Segment Overview

The market forecasting report covers market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

• End-user Outlook 
  • Primary and secondary 
  • Latent|tertiary 

•  Technology Outlook 
  • Laboratory testing/conventional testing
  • POC testing

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest Of World (ROW)
    • Brazil
    • Argentina 
    • Australia 

Syphilis Testing Market Scope
Market Report Coverage	Details
Page number	164
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 6.7%
Market Growth 2024-2028	USD 2,220.61 million
Market structure	Fragmented
YoY growth 2023-2024(%)	6.04
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 42%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, AdvaCare Pharma, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioLytical Laboratories Inc., Bloodworks Northwest, Calibre Scientific Inc., Danaher Corp., DiaSorin SpA, Everlywell Inc., F. Hoffmann La Roche Ltd., Hologic Inc., LetsGetChecked, Meril Life Sciences Pvt. Ltd., OK Biotech Co. Ltd., Omega Diagnostics Group Plc, OriGene Technologies Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the market between 2024 and 2028
• Precise estimation of the market size and its contribution to the market in focus on the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies' position and classification
• Accurate predictions about upcoming trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch